Fetal cardiomyopathy - In utero evaluation and clinical significance

Prenatal Diagnosis

Volumn 27, Issue 1, 2007, Pages 23-28

  Yinon, Yoav ^a,b   Yagel, Simcha ^c   Hegesh, Juluis ^a,b   Weisz, Boaz ^a,b   Mazaki Tovi, Shali ^a,b   Lipitz, Shlomo ^a,b   Achiron, Reuven ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Fetal cardiomyopathy; Prenatal echocardiography

Indexed keywords

CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL STUDY; CLUSTER ANALYSIS; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; GESTATION PERIOD; HEART FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHOTOGRAPHY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; VAGINAL DELIVERY; VIDEOTAPE;

ADULT; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33846409805     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1612     Document Type: Review

References (21)

1. Allan LD, Sharland GK, Milburn A, et al. 1994. Prospective diagnosis of 1006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 23: 1452-1458.
2. De Vore GR, Siassi B, Platt LD. 1984. Fetal echocardiography IV: M-mode assessment of ventricular size and contractility during the second and third trimesters of pregnancy in the normal fetus. Am J Obstet Gynecol 150: 981-988.
3. Gembruch U, Redel DA, Bald R, Hansmann M. 1993. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echocardiographic findings and pathophysiologic implications. Am Heart J 125: 1290-1301.
4. Griffin MJ, Hernandez A, Martin TC, et al. 1988. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 11: 139-144.
5. Guirgis NM, Casasoprane A, Magnier S, Kchouk H, Blot P, Azancot A. 1996. Diagnosis and outcome of fetal cardiomyopathies. Cardiol Young 6:Suppl.1 520 (abstr).
6. Gutgesell HP, Speer ME, Rosenberg HS. 1980. Characterization of the cardiomyopathy in infants of diabetic mothers. Circulation 61: 441-450.
7. Kanzaki T, Chiba Y. 1990. Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern. Fetal Diagn Ther 5: 168-174.
8. Keren A, Popp RL. 1992. Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622-1633.
9. Lewis AB. 1992. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 123: 1589-1593.
10. Manning JA, Sellers FS, Bynum RS, Keith JD. 1964. The medical management of clinical endocardial fibroelastosis. Circulation 29: 59-65.
11. Nield LE, Silverman ED, Taylor GP, et al. 2002. Maternal anti-Ro and anti-La antibody associated endocardial fibroelastosis. Circulation 105: 843-848.
12. Pedra SR, Hornberger LK, Leal SM, Taylor GP, Smallhorn JF. 2005. Cardiac function assessment with family history of nonhypertrophic cardiomyopathy: a prenatal and postnatal study. Pediatr Cardiol 26: 543-552.
13. Pedra SR, Smallhorn JF, Ryan G, et al. 2002. Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106: 585-591.
14. Schmidt KG, Birk E, Silverman NH, Scagnelli SA. 1989. Echocardiographic evaluation of dilated cardiomyopathy in the human fetus. Am J Cardiol 63: 599-605.
15. Shabetai R. 1988. Pathophysiology and differential diagnosis of restrictive cardiomyopathy. Cardiovasc Clin 19: 123-132.
16. Shapiro I, Degani S, Leibovitz Z, Ohel G, Tal Y, Abinader EG. 1998. Fetal cardiac measurements derived by transvaginal and transabdominal cross-sectional echocardiography from 14 weeks of gestation to term. Ultrasound Obstet Gynecol 12: 404-418.
17. Simpson JM. 2003. Cardiomyopathy in the fetus. In Fetal Cardiology, Yagel S, Silverman NH, Gembruch U (eds). Martin Dunitz, Taylor and Francis Group: London, New York.
18. Tan J, Silverman NH, Hoffman JIE, Villeqas M, Schmidt KG. 1992. Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to term. Am J Cardiol 70: 1459-1467.
19. Weller RJ, Weintraub R, Addonizio LJ, Chrisant M, Gersony WM, Hsu DT. 2002. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol 90: 501-506.
20. Yagel S, Cohen SM, Achiron R. 2001. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 17: 367-369.
21. Zielinsky P. 1991. Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus. Echocardiography 8: 661-668.